Vitamin D protects against hippocampal apoptosis related with seizures induced by kainic acid and pentylenetetrazol in rats
No Thumbnail Available
Date
2019
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objectives: The hippocampus is susceptible to damage in patients with epilepsy and in animals with seizures caused by excitotoxic agents. The effect of vitamin D on hippocampal apoptosis related with seizures has not been reported. However, epileptic patients have an increased risk of hypovitaminosis D which is most likely due to the effects of antiepileptic drugs. Therefore, in this study, it was aimed to evaluate the effects of vitamin D on hippocampal apoptosis related with seizures by using pentylenetetrazol (PTZ) and kainic acid (KA) in rats. Methods: Male Sprague Dawley rats, aged 5.5 weeks, were randomly divided into six groups: control, vitamin D, PTZ, KA, PTZ + vitamin D and KA + vitamin D groups. The groups that received vitamin D were given 500 IU/kg of vitamin D daily for two weeks in addition to a standard diet. At the end of this period, PTZ and KA were applied to trigger seizures in the rats in the seizure groups. 24 h after the administration of PTZ and KA, the rats were decapitated. In the hippocampal region, apoptosis was assessed by TUNEL and brain-derived neurotrophic factor (BDNF), Bax, caspase-3 and c-fos activation were evaluated by immunohistochemical method. Results: BDNF level increased while c-fos, Bax and caspase-3 levels decreased (p < 0.0001, in all) in the hippocampal neurons of the groups that were pre-treated with vitamin D before the administration of PTZ and KA, in comparison with the PTZ and KA groups. Vitamin D significantly decreased the number of apoptotic cells in these rats in comparison with the PTZ and KA groups (p < 0.0001). Conclusion: This study indicates that vitamin D has neuroprotective effects on hippocampal apoptosis induced by PTZ and KA in rats. With this study it is suggested that keeping vitamin D levels within normal limits may be beneficial for patients with epilepsy, especially children. © 2018 Elsevier B.V.
Description
Keywords
Animals , Apoptosis , bcl-2-Associated X Protein , Brain-Derived Neurotrophic Factor , Caspase 3 , Convulsants , Disease Models, Animal , Hippocampus , In Situ Nick-End Labeling , Kainic Acid , Male , Neurons , Neuroprotective Agents , Pentylenetetrazole , Proto-Oncogene Proteins c-fos , Rats , Rats, Sprague-Dawley , Seizures , Vitamin D , brain derived neurotrophic factor , caspase 3 , devit 3 , protein Bax , vitamin D , brain derived neurotrophic factor , caspase 3 , convulsant agent , kainic acid , neuroprotective agent , pentetrazole , protein Bax , protein c fos , vitamin D , animal experiment , animal model , animal tissue , apoptosis , Article , controlled study , drug efficacy , enzyme activation , hippocampal CA3 region , hippocampus , immunohistochemistry , kainic acid-induced seizure , male , neuroprotection , nonhuman , outcome assessment , pentylenetetrazole-induced seizure , priority journal , protein expression , randomized controlled trial , rat , TUNEL assay , animal , apoptosis , chemically induced , disease model , drug effect , hippocampus , metabolism , nerve cell , pathology , seizure , Sprague Dawley rat